Ro 50-3821
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ro 50-3821, covering 2013-07-18 to 2013-07-18. Get the full timeline:
Most recent: Clinical Trial Update: Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]